Skip to content

Elucidating the novel BRCA1 function as a Non-Genomic metabolic restraint in ER-positive breast cancer cell lines

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)33562-33576
Number of pages15
JournalOncotarget
Volume9
Issue number71
DOIs
DateAccepted/In press - 3 Aug 2018
DatePublished (current) - 11 Sep 2018

Abstract

Within populations carrying the same genetic predisposition, the penetrance of BRCA1 mutations has increased over time. Although linked to changes in lifestyle factors associated with energy metabolism, these observations cannot be explained by the established role of BRCA1 in DNA repair alone. We manipulated BRCA1 expression using tetracycline in the UBR60-bcl2 cell line (which has an inducible, tetracycline-regulated BRCA1 expression) and siRNA in oestrogen receptor(ER)-positive MCF7 and T47D breast cancer cells. Cellular responses to BRCA1 silencing and IGF-I actions were investigated using western blotting, 3-H Thymidine incorporation assay, cell fractionation and co-immunoprecipitation. We demonstrated that the loss of BRCA1 resulted in downregulation of a phosphorylated and inactive form of acetyl CoA Carboxylase-á (ACCA), with a concomitant increase in fatty acid synthase (FASN) abundance. BRCA1 was predominantly cytoplasmic in ER-positive breast cancer cells, compatible with the observation that BRCA1 physically associates with phosphorylated ACCA, which is a cytoplasmic protein. We also found that IGF-I induced de-phosphorylation of ACCA by reducing the interaction between BRCA1 and phosphorylated ACCA. BRCA1 deficiency enhanced the non-genomic effects of IGF-I, as well as the proliferative responses of cells to IGF-I. We characterized a novel, non-genomic role for BRCA1 in restraining metabolic activity and IGF-I anabolic actions.

    Research areas

  • BRCA1, IGF-I, cancer, p-ACCA, non-genomic

    Structured keywords

  • ICEP

Download statistics

No data available

Documents

Documents

  • Full-text PDF (final published version)

    Rights statement: This is the final published version of the article (version of record). It first appeared online via Oncotarget at http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=26093&path[]=81388 . Please refer to any applicable terms of use of the publisher.

    Final published version, 4.67 MB, PDF document

    Licence: CC BY

DOI

View research connections

Related faculties, schools or groups